Patents by Inventor Jin Jen

Jin Jen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11968206
    Abstract: A mechanism for building decentralized computer applications that execute on a distributed computing system. The present technology works within a web browser, client application, or other software and provides access to decentralized computer applications through the browser. The present technology is non-custodial, wherein a public-private key pair, which represents user identity, is created on a client machine and then directly encrypted by a third-party platform without relying on one centralized computing system.
    Type: Grant
    Filed: September 15, 2023
    Date of Patent: April 23, 2024
    Assignee: Magic Labs, Inc.
    Inventors: Fei-Yang Jen, Yi Wei Chen, Jaemin Jin, Hanyu Xue, Wentao Liu, Shang Li
  • Patent number: 8067240
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Grant
    Filed: November 22, 2010
    Date of Patent: November 29, 2011
    Assignees: Esoterix Genetic Laboratories, LLC, Johns Hopkins University School of Medicine
    Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
  • Publication number: 20110091892
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Application
    Filed: November 22, 2010
    Publication date: April 21, 2011
    Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
  • Patent number: 7846667
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Grant
    Filed: August 20, 2009
    Date of Patent: December 7, 2010
    Assignees: Genzyme Corporation, Johns Hopkins University
    Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
  • Patent number: 7709202
    Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: May 4, 2010
    Assignees: The Johns Hopkins University, Genzyne Corporation, The U.S.A. as represented by the Secretary of the HHS
    Inventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen L Madden, Jin Jen
  • Publication number: 20100100919
    Abstract: In a method of reducing and diagnosing upstream ingress noise in cable data system utilize a MAC/MAP management messages via a downstream path based on Cable Systems Interface Specification (DOCSIS) to provide precise control of gates deployed near the user side provide a powerful algorithm for CATV operators to mitigate ingress noise problem.
    Type: Application
    Filed: December 18, 2009
    Publication date: April 22, 2010
    Inventors: Jin-Jen Hsue, Wei-Chih Lu
  • Publication number: 20100062443
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Application
    Filed: August 20, 2009
    Publication date: March 11, 2010
    Inventors: Jin Jen, Gary A. Beaudry, Stephen L. Madden, Arthur H. Bertlesen, David Sidransky
  • Patent number: 7639494
    Abstract: An electronic apparatus includes a first machine assembly, a second machine assembly having a pushing part and a first locking part, and a connection mechanism. The connection mechanism connecting the first and the second machine assemblies includes a body, a driven element having a second locking part and a third locking part, and a fourth locking part disposed on the body. Two ends of the body are pivoted to the first assembly and the second assembly respectively. The driven element is movably disposed on the body. When the second assembly is at a first position and the connection mechanism is at a second position, the second assembly is located above the first assembly, the pushing part and the first locking part are far from the connection mechanism, and the fourth locking part locks the third locking part to restrict the relative movement between the driven element and the body.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: December 29, 2009
    Assignee: Inventec Corporation
    Inventor: Jin-Jen Lin
  • Publication number: 20090270265
    Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.
    Type: Application
    Filed: July 27, 2007
    Publication date: October 29, 2009
    Applicants: The United States of America as Represented by the Secretary of Health and Human Services, Genzyme Corporation, The Johns Hopkins University School of Medicine
    Inventors: Mariana NACHT, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
  • Publication number: 20090124795
    Abstract: Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.
    Type: Application
    Filed: April 10, 2008
    Publication date: May 14, 2009
    Applicant: JOHNS HOPKINS UNIVERSITY
    Inventors: Makiko Fliss, David Sidransky, Jin Jen, Kornelia Polyak, Bert Vogelstein, Kenneth W. Kinzler
  • Publication number: 20090050027
    Abstract: An electronic apparatus includes a first machine assembly, a second machine assembly having a pushing part and a first locking part, and a connection mechanism. The connection mechanism connecting the first and the second machine assemblies includes a body, a driven element having a second locking part and a third locking part, and a fourth locking part disposed on the body. Two ends of the body are pivoted to the first assembly and the second assembly respectively. The driven element is movably disposed on the body. When the second assembly is at a first position and the connection mechanism is at a second position, the second assembly is located above the first assembly, the pushing part and the first locking part are far from the connection mechanism, and the fourth locking part locks the third locking part to restrict the relative movement between the driven element and the body.
    Type: Application
    Filed: January 29, 2008
    Publication date: February 26, 2009
    Applicant: INVENTEC CORPORATION
    Inventor: Jin-Jen Lin
  • Patent number: 7468425
    Abstract: We have discovered p40, the shortest variant of a new human p53 homologue (p40/p51/p63/p73H). We have also found that it plays a role in cancer. Low level amplification of the p40 locus accompanied by RNA and protein overexpression was observed in primary lung cancers, and head and neck cancer cell lines. P40 protein overexpression in primary lung tumors was limited to squamous cell carcinoma, tumors known to harbor a high frequency of p53 mutations. Overexpression of p40 in Rat 1a cells led to an increase in soft agar growth and tumor size in mice. We searched for p40 binding proteins using the yeast two-hybrid system. P53 was the most common binding target of the 1.6×106 clones screened from a mouse embryonic library. Moreover, coexpression of p40 and p53 led to a decrease in p53 transcriptional activity. Our results support the notion that p40 plays an oncogenic role in human cancer.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: December 23, 2008
    Assignee: The Johns Hopkins University
    Inventors: David Sidransky, Jin Jen, Barry Trink, Edward A. Ratovitski
  • Publication number: 20080168518
    Abstract: In a method of reducing upstream ingress noise in cable data system, downstream management messages containing information about user group data uploading time and channel frequency are broadcasted by a headend of the cable data system. The broadcasted downstream management messages are monitored, so as to determine an upstream channel connection time schedule for the user groups. Each user group is connected to an upstream channel of the headend only at a data uploading time scheduled for that user group. As a result, ingress noise existed in the user group will be uploaded to the headend only when the user group is connected to the headend. Therefore, accumulation of upstream ingress noise at the headend is effectively reduced, and the headend network can maintain good signal quality to ensure best network connection.
    Type: Application
    Filed: January 5, 2007
    Publication date: July 10, 2008
    Inventors: Jin-Jen Hsue, Wei-Chih Lu
  • Patent number: 7332590
    Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: February 19, 2008
    Assignees: The United States of America as Represented by the Department of Health and Human Services, Genzyme Corporation, The Johns Hopkins University of Medicine
    Inventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
  • Publication number: 20070218511
    Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell, and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
    Type: Application
    Filed: August 14, 2006
    Publication date: September 20, 2007
    Inventors: Jin Jen, Gary Beaudry, Stephen Madden, Arthur Bertlesen, David Sidransky
  • Publication number: 20050136403
    Abstract: We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers (NSCLC). Separation of normal and tumor samples, as well as histopathological subtypes, was evident using the 3,921 most abundant transcript tags. This distinction remained when just 115 highly differentially expressed transcript tags were used. Furthermore, these 115 transcript tags clustered into groups that were suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, while squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation.
    Type: Application
    Filed: August 16, 2002
    Publication date: June 23, 2005
    Inventors: Mariana Nacht, Tatiana Dracheva, David Sidransky, Stephen Madden, Jin Jen
  • Publication number: 20040018538
    Abstract: Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.
    Type: Application
    Filed: June 24, 2003
    Publication date: January 29, 2004
    Applicant: Johns Hopkins University
    Inventors: Makiko Fliss, David Sidransky, Jin Jen, Kornelia Polyak, Bert Vogelstein, Kenneth W. Kinzler
  • Patent number: 6605433
    Abstract: Mitochondrial mutations occur as a product of contact of a person with an environmental pollutant. Mitochondrial mutations are readily detectable in body fluids. Measurement of mitochondrial mutations in body fluids can be used as a dosimeter to monitor exposure to the environmental pollutant. Mitochondrial mutations can also be detected in cancer patients. Probes and primers containing mutant mitochondrial sequences can be used to monitor patient condition.
    Type: Grant
    Filed: March 15, 2000
    Date of Patent: August 12, 2003
    Assignee: The Johns Hopkins University
    Inventors: Makiko Fliss, David Sidransky, Jin Jen, Komelia Polyak, Bert Vogelstein, Kenneth W. Kinzler
  • Patent number: 6587350
    Abstract: An ejection mechanism for modular electronic elements is used for ejecting a modular electronic element housed in a housing chamber of an electronic device. The ejection mechanism is located in the housing chamber. By moving only one driving member, the latching relationship of the modular electronic element may be released and the modular electronic element may be ejected out of the housing chamber to facilitate replacement of various types of modular electronic elements.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: July 1, 2003
    Assignee: Inventec Corporation
    Inventors: Jin Jen Lin, Sung Ming Song
  • Publication number: 20030113774
    Abstract: We have discovered p40, the shortest variant of a new human p53 homologue (p40/p51/p63/p73H). We have also found that it plays a role in cancer. Low level amplification of the p40 locus accompanied by RNA and protein overexpression was observed in primary lung cancers, and head and neck cancer cell lines. P40 protein overexpression in primary lung tumors was limited to squamous cell carcinoma, tumors known to harbor a high frequency of p53 mutations. Overexpression of p40 in Rat 1a cells led to an increase in soft agar growth and tumor size in mice. We searched for p40 binding proteins using the yeast two-hybrid system. P53 was the most common binding target of the 1.6×106 clones screened from a mouse embryonic library. Moreover, coexpression of p40 and p53 led to a decrease in p53 transcriptional activity. Our results support the notion that p40 plays an oncogenic role in human cancer.
    Type: Application
    Filed: October 22, 2002
    Publication date: June 19, 2003
    Applicant: The Johns Hopkins University
    Inventors: David Sidransky, Jin Jen, Barry Trink, Edward A. Ratovitski